Tuberculosis

Geneva, 18 June 2013 - The first affordable generic version of linezolid (600mg tablet), a drug used to treat drug-resistant tuberculosis (DR-TB), has been reviewed by the Global Fund Expert Review...

Statements, Speeches, Letters – Last updated 18 June 2013
msfaccess.org/content/first-generic-source-dr-tb-drug-linezolid-eligible-procurement

Indian government drug tender process leads to deadly delay in drug supply New Delhi, 17 June 2013 – The Indian government must urgently address the persistent issues and almost routine delays...

Press Release – Last updated 17 June 2013
msfaccess.org/about-us/media-room/press-releases/india-must-address-worrying-stock-out-tuberculosis-drugs

Geneva, 13 June 2013 - The World Health Organization has today issued interim guidance on the use of bedaquiline, the first new drug to treat tuberculosis in 50 years, which received accelerated approval...

Statements, Speeches, Letters – Last updated 13 June 2013
msfaccess.org/content/msf-welcomes-who-guidelines-tb-drug-bedaquiline-more-work-needed

This analysis of the TB diagnostics research and development (R&D) pipeline, along with an accompanying report on the TB drug development pipeline, stem from the frustration of MSF...

Report – Last updated 01 October 2006
msfaccess.org/content/tuberculosis-diagnosis-and-drug-sensitivity-testing-overview-current-diagnostic-pipeline

Multimedia – Last updated 22 March 2013
msfaccess.org/content/test-me-treat-me-dr-tb-manifesto

Those lucky enough to get access to care for drug-resistant tuberculosis go through two years of painful and largely ineffective treatment, taking up to twenty pills a day. Doctors and patients are...

Web article – Last updated 19 March 2013
msfaccess.org/content/infographics-drug-resistant-tuberculosis

People living with MDR-TB and their healthcare providers call for urgent action  Geneva, 19 March 2013 — If measures to tackle multidrug-resistant tuberculosis (MDR-TB) are not significantly...

Press Release – Last updated 21 March 2013
msfaccess.org/about-us/media-room/press-releases/sluggish-response-risks-squandering-historic-opportunity-tackle

Few children at the paediatric tuberculosis hospital in Dushanbe look as active and healthy as Shirinmo. The little girl is bright and busy as she crawls across the waiting room floor. But get closer...

Web article – Last updated 12 March 2013
msfaccess.org/content/tajikistan-msf-treats-its-youngest-ever-patient-multidrug-resistant-tb

BACKGROUND: Scaling up treatment for multi-drug-resistant tuberculosis is a global health priority. However, current treatment regimens are long and associated with side effects, and default...

In Medical Journals / Research Articles – Last updated 23 February 2013
msfaccess.org/content/strategies-reducing-treatment-default-drug-resistant-tuberculosis-systematic-review-and-meta

Multimedia – Last updated 15 January 2013
msfaccess.org/content/new-drug-offers-real-potential-better-treatment-options-tb